1. Noninvasive Measurement of Cardiac Output in Hemodialysis Patients by Task Force Monitor: A Comparison with the Transonic System
- Author
-
Thomas M. Kitzler, Peter Kotanko, Olga Sergeyeva, Nathan W. Levin, Alice T. Morris, and Falko Skrabal
- Subjects
Adult ,Male ,medicine.medical_specialty ,Cardiac output ,medicine.medical_treatment ,Thermodilution ,Biomedical Engineering ,Biophysics ,Bioengineering ,Dialysis patients ,Cardiography, Impedance ,Cohort Studies ,Biomaterials ,Renal Dialysis ,Intensive care ,Internal medicine ,Linear regression ,medicine ,Humans ,Minimally Invasive Surgical Procedures ,Cardiac Output ,Aged ,Carbon Monoxide ,medicine.diagnostic_test ,business.industry ,Task force ,Reproducibility of Results ,General Medicine ,Maintenance hemodialysis ,Middle Aged ,Surgery ,Impedance cardiography ,Cardiology ,Female ,Hemodialysis ,business - Abstract
Cardiovascular disease is the leading cause of morbidity and mortality in maintenance hemodialysis (MHD) patients. The Transonic (TRS; Transonic Systems, Ithaca, NY) device is frequently used for determination of cardiac output (CO) by an indicator dilution technique. The Task Force Monitor (TFM; CN Systems, Graz, Austria) has gained attention as noninvasive tool for continuous beat-to-beat assessment of cardiovascular variables, including CO by impedance cardiography. Despite its use in cardiology and intensive care settings, the TFM has yet not been validated in dialysis patients. This study compares CO measurements in 12 MHD patients by TFM and TRS. Bland-Altman and regression analysis were used. CO was measured simultaneously by TRS and TFM. Average CO was 5.4 L/min by TRS and 5.0 L/min by TFM, respectively. Bland-Altman analysis revealed no significant systematic differences between the two methods (mean difference: 0.4 L/min; SD: 0.6; p > 0.05). Linear regression analysis showed significant correlation between both techniques (r = 0.802, p = 0.002). The SD of mean individual CO values was 1.1 L/min with TRS and 0.8 L/min with TFM, respectively.CO measured by TFM and TRS does not differ significantly, thus making the TFM an attractive noninvasive tool for the continuous beat-to-beat assessment of CO in MHD patients.
- Published
- 2007
- Full Text
- View/download PDF